Induction of Systemic and Mucosal Immune Responses in Mice Orally Administered with Recombinant Attenuated Salmonella Expressing Subunits of P Fimbriae of Avian Pathogenic Escherichia coli

마우스에서 조류 병원성 대장균의 P Fimbriae subunits을 발현하는 약독화 살모넬라균 경구 접종 후 면역 반응 유도 실험

  • Oh, In-Gyeong (College of Veterinary Medicine, Chonbuk National University) ;
  • Moon, Bo-Mi (College of Veterinary Medicine, Chonbuk National University) ;
  • Lee, John-Hwa (College of Veterinary Medicine, Chonbuk National University) ;
  • Hur, Jin (College of Veterinary Medicine, Chonbuk National University)
  • 오인경 (전북대학교 수의과대학) ;
  • 문보미 (전북대학교 수의과대학) ;
  • 이존화 (전북대학교 수의과대학) ;
  • 허진 (전북대학교 수의과대학)
  • Accepted : 2011.06.13
  • Published : 2011.06.30

Abstract

Avian pathogenic Escherichia coli (APEC) causes a number of extraintestinal diseases in poultry. A virulence factor, P-fimbriae is firmly associated with the diseases. In this study, to develop an effective vaccine for the prevention of APEC, recombinant attenuatted Salmonella Typhimurium vaccines expressing PapA and PapG of P-fimbriae were evaluated whether these induced protective immune responses in murine models. Female BALB/c mice were primed and boosted orally at 7 and 10 weeks of age. In all immunized mice, the antigen-specific serum IgG levels were remained higher than those in the control mice from the fourth week post inoculation till the end of this study. In addition, antigen-specific serum IgG levels in the prime-booster immunized mice were enhanced as compared to the single immunized mice among each immunized group. The antigen-specific mucosal IgA levels in the mice immunized with each strain also induced higher than those in control mice. In addition, serum IgG and fecal IgA levels in mice administered with the combination of both strains were highly induced compared to those in mice immunized with each strain alone. These results indicated that PapA and PapG worked together for inducing high immune responses. To partly discern the nature of immunity induced by the strains, we quantified serum IgG subtypes IgG1 and IgG2a specific to antigens. The PapA and PapG strains biased the immunity to the Th1-type, as determined by the IgG2a/IgG1 ratio. On the other hand, the immunization with the both strains in combination produced mixed Th1- and Th2-type immune responses. These indicated that immunization with the combination of PapA and PapG could elicit both humoral and cell-mediated immunities.

조류병원성 대장균 (APEC)은 가금에서 많은 장관외 질병을 야기한다. 병원성 인자 중 하나인 P-fimbriae 또한 질병과 밀접하게 관련되어 있다. 이번 연구에서 마우스에 P-fimbriae의 subunit 들인 PapA와 PapG를 발현하는 재조합 약독화 Salmonella Typhimurium 백신균주 접종 후 APEC 방어에 필요한 면역반응 유도 여부를 알아보기 위한 실험을 수행하였다. 각 백신 균주로 경구 접종 후 각 항원에 대한 serum IgG 항체 역가는 접종 후 4주째부터 대조군에 비해 항체 역가가 높게 유도되기 시작하여 실험이 끝날 때까지 높은 항체 역가가 계속 유지 되었다. 한번 접종 된 경우보다 추가 접종 된 군에서 보다 높은 항체 역가가 관찰되었다. 더불어 각 항원에 대한 mucosal IgA 역가 또한 높게 유도되었다. 두 균주를 혼합하여 접종 하였을 경우에는 각 백신 균주를 접종하였을 경우보다 높은 serum IgG와 mucosal IgA의 역가가 관찰되었다. 이 결과는 이들 백신 균주가 면역원성이 있음을 확인하는 결과였다. 또한 helper T cells type을 알아보기 위해 IgG1과 IgG2a의 항체 역가를 측정하여 본 결과 각 백신 균주를 접종하였을 경우에는 IgG2a의 항체 역가가 IgG1의 항체 역가 보다 월등히 높은 이들 백신 균주를 접종 하였을 경우에는 Th1-type의 면역 반응이 유도되지만 두 백신 균주를 혼합 접종하였을 경우에는 Th1-과 Th2-type 모두를 유도하는 것으로 관찰되었다. 이 결과를 통해서 이들 두 백신 균주를 혼합 접종 하였을 경우에는 세포성 면역뿐만 아니라 체액성 면역 모두를 유도할 수 있음을 확인할 수 있었다.

Keywords

References

  1. Bastiani M, Vidotto MC, Horn F. An avian pathogenic Escherichia coli isolate induces caspase 3/7 activation in J774 macrophages. FEMS Microbiol Lett 2005; 253: 133-140. https://doi.org/10.1016/j.femsle.2005.09.024
  2. Blanco JE, Blanco M, Mora A, Blanco J. Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain. J Clin Microbiol 1997; 35: 2184-2185.
  3. Bongers JF, Franssen F, Elbers AR, Tielen MJ. Antimicrobial resistance of Escherichia coli isolates from the fecal flora of veterinarians with different professional specialties. Vet Q 1995; 17: 146-149. https://doi.org/10.1080/01652176.1995.9694555
  4. Branger CG, Fetherston JD, Perry RD, Curtiss R 3rd. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Adv Exp Med Biol 2007; 603: 387-399.
  5. Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Vet Res 1999; 30: 299-316.
  6. Ewers C, Janssen T, Wieler LH. Avian pathogenic Escherichia coli (APEC). Berl Munch Tierarztl Wochenschr 2003; 116: 381-395.
  7. Gulig PA, Curtiss R 3rd. Plasmid-associated virulence of Salmonella Typhimurium. Infect Immun 1987; 55: 2891-2901.
  8. Gyimah JE, Panigrahy B, Wiliams JD. Immunogenicity of an Escherichia coli multivalent pilus vaccine in chickens. Avian Dis 1986; 30: 687-689. https://doi.org/10.2307/1590569
  9. Heller ED, Smith HW. The incidence of antibiotic resistance and other characteristics amongst Escherichia coli strains causing fatal infection in chickens: the utilization of these characteristics to study the epidemiology of the infection. J Hyg 1973; 71: 771-781. https://doi.org/10.1017/S0022172400023032
  10. Kang HY, Srinivasan J, Curtiss R 3rd. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 2002; 70: 1739-1749. https://doi.org/10.1128/IAI.70.4.1739-1749.2002
  11. Kariywasam S, Wilkie BN, Hunter DB, Gyles CL. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens. Avian Dis 2002; 46: 668-678. https://doi.org/10.1637/0005-2086(2002)046[0668:SAMART]2.0.CO;2
  12. Lynne AM, Foley SL, Nolan LK. Immune responses to recombinant Escherichia coli Iss protein in poultry. Avian Dis 2006; 50: 273-276. https://doi.org/10.1637/7441-092105R.1
  13. Matoba N, Geyer BC, Kilbourne J, Alfsen A, Bomsel M, Mor TS. Humoral immune responses by prime-boost heterologous route immunizations with $CTB-MPR_{649-684}$, a mucosal subunit HIV/AIDS vaccine candidate. Vaccine 2006; 24: 5047-5055. https://doi.org/10.1016/j.vaccine.2006.03.045
  14. Nakayama K, Kelly SM, Curtiss R 3rd. Construction of an $Asd^+$ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio Technology 1998; 6: 693-697.
  15. Ngeleka M, Brereton L, Brown G, Fairbrother JM. Pathotypes of avian Escherichia coli as related to tsh-, pap-, pil-, and iuc-DNA sequences, and antibiotic sensitivity of isolates from internal tissues and the cloacae of broilers. Avian Dis 2002; 46: 143-152. https://doi.org/10.1637/0005-2086(2002)046[0143:POAECA]2.0.CO;2
  16. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001; 14: 430-445. https://doi.org/10.1128/CMR.14.2.430-445.2001
  17. O'Hagan DT, MacKichan ML, Singh M. Recent development in adjuvants for vaccines against infectious diseases. Biomol Eng 2001; 18: 69-85. https://doi.org/10.1016/S1389-0344(01)00101-0
  18. Palaszynski S, Pinkner J, Leath S, Barren P, Auguste CG, Burlein J, Hultgren S, Langermann S. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections. Dev Biol Stand 1998; 92: 117-122.
  19. Pascual DW, Hone DM, Hall S, vanGinkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell responses. Infect Immun 1999; 67: 6249-6256.
  20. Pourbakhsh SA, Boulianne M, Martineau-Doize B, Fairbrother JM. Virulence mechanisms of avian fimbriated Escherichia coli in experimentally inoculated chickens. Vet Microbiol 1997; 58: 195-213. https://doi.org/10.1016/S0378-1135(97)00163-6
  21. Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J, Leenhouts K. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunizations. Vaccine 2006; 24: 3900-3908. https://doi.org/10.1016/j.vaccine.2006.02.040
  22. Roland K, Karaca K, Sizemore D. Expression of Escherichia coli antigens in Salmonella typhimurium as a vaccine to prevent airsacculitis in chickens. Avian Dis 2004; 48: 595-605. https://doi.org/10.1637/7178-031004R1
  23. Strindelius L, Filler M, Sjoholm I. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Vaccine 2004; 22: 3797-3808. https://doi.org/10.1016/j.vaccine.2003.12.035
  24. Vandemaele F, Assadzadeh A, Derijcke J, Vereecken M, Goddeeris BM. Avian pathogenic Escherichia coli (APEC). Tijdschr Diergeneeskd 2002; 127: 582-588.
  25. Vindurampulle CJ, Cuberos LF, Barry EM, Pasetti MF, Levine MM. Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy. Vaccine 2004; 22: 3744-3750. https://doi.org/10.1016/j.vaccine.2004.03.025
  26. Wu S, Pascual DW, VanCott JL, McGhee JR, Maneval DR, Levine MM, Hone DM. Immune response to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E.coli (ETEC) in the absence of the CFA/I positive regulator cfaR. Infect Immun 1995; 63: 4933-4938.
  27. Yerushalmi Z, Smorodinsky NI, Naveh MW, Ron EZ. Adherence pili of avian strains of Escherichia coli O78. Infect Immun 1990; 58: 1129-1131.
  28. Zhao X, Zhang M, Li Z, Frankel FR. Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag. J Virol 2006; 80: 8880-8890. https://doi.org/10.1128/JVI.00894-06